2021 ASCO Direct St. Louis | Early Stage Breast Cancer Summary | Dr. Cynthia Ma

2021 ASCO Direct St. Louis | Early Stage Breast Cancer Summary | Dr. Cynthia Ma

2021 ASCO Direct St. Louis | Breast Cancer Panel DiscussionПодробнее

2021 ASCO Direct St. Louis | Breast Cancer Panel Discussion

Radiation Therapy Based on LUMINA Trial | Cynthia Ma, MD, PhD | ASCO22 Breast Cancer UpdatesПодробнее

Radiation Therapy Based on LUMINA Trial | Cynthia Ma, MD, PhD | ASCO22 Breast Cancer Updates

2021 ASCO Direct Jacksonville | Early Stage Breast Cancer Summary | Dr. Hatem SolimanПодробнее

2021 ASCO Direct Jacksonville | Early Stage Breast Cancer Summary | Dr. Hatem Soliman

2021 ASCO Direct San Francisco | Early Stage Breast Cancer Summary | Dr. Mark PegramПодробнее

2021 ASCO Direct San Francisco | Early Stage Breast Cancer Summary | Dr. Mark Pegram

2021 ASCO Direct St. Louis | Metastatic Breast Cancer Summary | Dr. Jane MeiselПодробнее

2021 ASCO Direct St. Louis | Metastatic Breast Cancer Summary | Dr. Jane Meisel

Cynthia Ma, MD | Key Takeaways on Breast Cancer at 2019 ASCO Direct Highlights St. LouisПодробнее

Cynthia Ma, MD | Key Takeaways on Breast Cancer at 2019 ASCO Direct Highlights St. Louis

Cynthia Ma, MD | Advice on Breast Cancer at 2019 ASCO Direct Highlights St. LouisПодробнее

Cynthia Ma, MD | Advice on Breast Cancer at 2019 ASCO Direct Highlights St. Louis

Cythina Ma, MD | Advances in Breast Cancer at 2019 ASCO Direct Highlights St. LouisПодробнее

Cythina Ma, MD | Advances in Breast Cancer at 2019 ASCO Direct Highlights St. Louis

2021 ASCO Direct San Francisco | Breast Cancer Panel DiscussionПодробнее

2021 ASCO Direct San Francisco | Breast Cancer Panel Discussion

2021 Best of Breast | Case 2 Early StageПодробнее

2021 Best of Breast | Case 2 Early Stage

PREDICT+ underestimates survival of patients with HER2+ early breast cancerПодробнее

PREDICT+ underestimates survival of patients with HER2+ early breast cancer

Dr. Cynthia Ma on the METRIC Trial in Triple-Negative Breast CancerПодробнее

Dr. Cynthia Ma on the METRIC Trial in Triple-Negative Breast Cancer

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancerПодробнее

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

CARG Score Chemotherapy Options ABCSG 18 Trial | Cynthia Ma, MD, PhD | ASCO22 Breast Cancer UpdatesПодробнее

CARG Score Chemotherapy Options ABCSG 18 Trial | Cynthia Ma, MD, PhD | ASCO22 Breast Cancer Updates

2021 ASCO Direct St. Louis | Non-Prostate Cancer Summary | Dr. Russell PachynskiПодробнее

2021 ASCO Direct St. Louis | Non-Prostate Cancer Summary | Dr. Russell Pachynski

Dr. Cynthia Ma on Immunotherapy in TNBCПодробнее

Dr. Cynthia Ma on Immunotherapy in TNBC